93 results
Page 4 of 5
8-K
EX-99.1
bby7wsqgpeu o4v50uu2
16 Sep 20
Other Events
4:07pm
8-K
EX-99.1
6mdu q4gj4
11 Aug 20
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2020 Financial Results
4:05pm
424B4
9hessc4b7wb78
8 Jul 20
Prospectus supplement with pricing info
4:35pm
8-K
EX-99.1
7fbcmtl
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
8-K
EX-99.2
pud2t8bcq7cclt376l
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
DRS
EX-10.56
ewx y4z7jjt
23 Jun 20
Draft registration statement
12:00am
DRS
i310pk4ns9n56
23 Jun 20
Draft registration statement
12:00am
8-K
EX-99.1
6dc506bk635eu5
19 Jun 20
Patent License Agreement
5:26pm
8-K
dsyzslfch13yepwf37z
19 Jun 20
Patent License Agreement
5:26pm
8-K
o5fny
15 Jun 20
Entry into a Material Definitive Agreement
4:13pm
8-K
ukdg8txr4xh jw
29 May 20
Vir Biotechnology and Biogen Execute Agreement to ManufactureSARS-CoV-2 Antibodies for PotentialCOVID-19 Treatment
4:06pm
8-K
EX-99.1
ydr43ehh
29 May 20
Vir Biotechnology and Biogen Execute Agreement to ManufactureSARS-CoV-2 Antibodies for PotentialCOVID-19 Treatment
4:06pm
8-K
EX-99.1
l5h1vci
12 May 20
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2020 Financial Results
4:05pm
DEFA14A
rnkjk v52015a
8 May 20
Additional proxy soliciting materials
4:10pm
8-K
40x3ab8b
10 Apr 20
Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture ofSARS-COV-2 Antibodies for Potential COVID-19 Treatment
8:01am
8-K
EX-99.1
qjm90z xo
10 Apr 20
Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture ofSARS-COV-2 Antibodies for Potential COVID-19 Treatment
8:01am